President
CurrentFuture Medical Services, LLC (FMS) was formed in anticipation of FDA Clearance of the OrthoGold Low Intensity SoftWave Device. FDA Clearance was received on December 21 2018. FMS is one of the initial distributors for Tissue Regeneration Technologies, LLC (TRT) and will focus efforts on servicing the Urology, OBGYN, Orthopedics, and Sports Medicine markets. The OrthoGold is currently in use among top Urology and Orthopedic groups in the US and around the world. It is also being used by the NBA, NFL, MLB and many other College, Olympic and professional Athletic teams. We have been waiting for official FDA Clearance for many years and are very excited to offer this amazing technology to the broad market. We are also very excited and proud to announce our recent FDA approval for the treatment of diabetic foot ulcers!! We hope that our technology will improve the lives of millions of people suffering from this difficult and threatening condition!!